.gif "IP Gear")
- Joined
- Jul 16, 2018
- Messages
- 313
JCR & JIAIDSS: Low doses of aspirin may be effective in inhibiting HIV infection and spread!
Recently, scientists from institutions such as the University of Manitoba in Canada found that low-dose aspirin maybe can inhibit the spread of HIV, the relevant research published in the International Journal of Controlled Release and the Journal of the International AIDS Society.
The HIV infection rate is still high in the population, especially among young African women. In this study, researchers tested acetylsalicylic acid (ASA Or aspirin) and other anti-inflammatory drugs on HIV-targeted cells by conducting a joint study of a group of women at low risk of HIV in Kenya.The results of the previous study were published in the Journal of the International AIDS Society, and the results were based on the role of inflammation in the spread of HIV.
The spread of the virus requires susceptible target cells in the human host's body. Active immune cells are often very susceptible to HIV infection compared to other cells, and researchers know that inflammation often targets activated HIV. Brought to the female reproductive tract.The study, funded by institutions such as the Canadian Institutes of Health, found that aspirin can be used as an effective anti-inflammatory drug to reduce the number of 35% of HIV-targeted cells in the female reproductive tract.In addition,the results of the study showed that the number of HIV-targeted cells in the female body taking aspirin was reduced to the level of Kenyan women who had been infected with high-risk HIV but had never been infected for many years.
The ultimate goal of the researchers was to develop a new tool to effectively prevent HIV infection and transmission. In this study, the researchers gave participants low doses of aspirin (the long-term use of drugs to prevent cardiovascular disease). Participants said they prefer the drug aspirin because people don't associate it with AIDS, which means that aspirin may be used regularly in the future.
Recently, scientists from institutions such as the University of Manitoba in Canada found that low-dose aspirin maybe can inhibit the spread of HIV, the relevant research published in the International Journal of Controlled Release and the Journal of the International AIDS Society.
The HIV infection rate is still high in the population, especially among young African women. In this study, researchers tested acetylsalicylic acid (ASA Or aspirin) and other anti-inflammatory drugs on HIV-targeted cells by conducting a joint study of a group of women at low risk of HIV in Kenya.The results of the previous study were published in the Journal of the International AIDS Society, and the results were based on the role of inflammation in the spread of HIV.
The spread of the virus requires susceptible target cells in the human host's body. Active immune cells are often very susceptible to HIV infection compared to other cells, and researchers know that inflammation often targets activated HIV. Brought to the female reproductive tract.The study, funded by institutions such as the Canadian Institutes of Health, found that aspirin can be used as an effective anti-inflammatory drug to reduce the number of 35% of HIV-targeted cells in the female reproductive tract.In addition,the results of the study showed that the number of HIV-targeted cells in the female body taking aspirin was reduced to the level of Kenyan women who had been infected with high-risk HIV but had never been infected for many years.
The ultimate goal of the researchers was to develop a new tool to effectively prevent HIV infection and transmission. In this study, the researchers gave participants low doses of aspirin (the long-term use of drugs to prevent cardiovascular disease). Participants said they prefer the drug aspirin because people don't associate it with AIDS, which means that aspirin may be used regularly in the future.
